Detalhe da pesquisa
1.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
2.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414060
3.
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 200(2): 187-196, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210485
4.
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
Br J Haematol
; 196(3): 649-659, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622447
5.
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
Am J Hematol
; 97(7): 877-884, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389534
6.
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
Br J Haematol
; 193(1): 181-187, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469083
7.
Kidney Transplantation in Monoclonal Immunoglobulin Deposition Disease: A Report of 6 Cases.
Am J Kidney Dis
; 78(5): 755-759, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961923
8.
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
Ann Hematol
; 100(12): 2997-3005, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463804
9.
Organisational responses to mitigate the effects of COVID-19 on healthcare workers: a qualitative case study from Bogotá, Colombia.
BMC Health Serv Res
; 21(1): 792, 2021 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380486
10.
Supportive Care in AL Amyloidosis.
Acta Haematol
; 143(4): 335-342, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235118
11.
Factors influencing delivery of intersectoral actions to address infant stunting in Bogotá, Colombia - a mixed methods case study.
BMC Public Health
; 20(1): 925, 2020 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534569
12.
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Eur J Haematol
; 102(5): 389-394, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719772
13.
Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.
Biol Blood Marrow Transplant
; 23(8): 1269-1275, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434927
14.
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling.
Haematologica
; 102(10): 1776-1784, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751557
15.
Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.
Ann Hematol
; 93(1): 107-11, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24218189
16.
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma.
Hemasphere
; 8(5): e76, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716147
17.
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma.
J Clin Oncol
; 42(14): 1665-1675, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358946
18.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res
; 30(10): 2085-2096, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466644
19.
Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.
Haematologica
; 98(7): 1142-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23645688
20.
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
Cancers (Basel)
; 15(21)2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958434